glp 1 incretin The system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes GLP-1: Actions on Beta-cell Mass

Tirzepatide is a GLP-1/GIP receptor agonist that has been studied in FDA-approved medications such as Mounjaro

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

The use of branded ingredients allows private label partners to leverage established research narratives, ingredient storytelling, and clinical positioning strategies in their marketing materials

Learn how this medical weight management option may work for you.

Regulate leptin, another fullness hormone, to help you feel full longer

Noom's GLP-1 Companion is a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off